Robert James Wills

Filings by Robert James Wills span 4 companies, the busiest being CymaBay Therapeutics, Inc., Oncternal Therapeutics, Inc. and Alpha Cognition Inc. Between 16 June 2016 and 21 August 2026, the trades on record add up to 17 filings.

On the open market, the record shows 12 purchases worth €560k and 1 sale worth €8,184. Netting one side against the other leaves €552k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants. 2026 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €54k. On 7 out of 12 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 24 August 2026, the filings show an open-market purchase worth €82k in Alpha Cognition Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.